Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Drew Weissman and Norbert Pardi.
Drew Weissman
Connection Strength
1.663
Norbert Pardi
  1. Development of vaccines and antivirals for combating viral pandemics. Nat Biomed Eng. 2020 12; 4(12):1128-1133.
    View in: PubMed
    Score: 0.916
  2. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host Microbe. 2021 01 13; 29(1):23-31.e4.
    View in: PubMed
    Score: 0.229
  3. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
    View in: PubMed
    Score: 0.224
  4. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 2021 08 27; 373(6558):991-998.
    View in: PubMed
    Score: 0.060
  5. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Mol Ther. 2021 11 03; 29(11):3293-3304.
    View in: PubMed
    Score: 0.059
  6. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.059
  7. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. NPJ Vaccines. 2021 Apr 09; 6(1):50.
    View in: PubMed
    Score: 0.059
  8. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation. Immunity. 2020 12 15; 53(6):1281-1295.e5.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.